Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Neurotherapeutics
Published in: Neurotherapeutics 1/2011

01-01-2011

Neuroimaging of Cerebral Ischemia and Infarction

Authors: Carlos Leiva-Salinas, Max Wintermark, Chelsea S. Kidwell, M.D.

Published in: Neurotherapeutics | Issue 1/2011

Login to get access

Summary

The imaging workup for patients with suspected acute ischemic stroke has advanced significantly over the past few years. Evaluation is no longer limited to noncontrast computed tomography, but now frequently also includes vascular and perfusion imaging. Although acute stroke imaging has made significant progress in the last few decades with the development of multimodal approaches, there are still many unanswered questions regarding their appropriate use in the setting of daily patient care. It is important for all physicians taking care of stroke patients to be familiar with current multimodal computed tomography and magnetic resonance imaging techniques, including their strengths, limitations, and their role in guiding therapy.
Appendix
Available only for authorised users
Literature
1.
Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia—the ischemic penumbra. Stroke 1981;12:723–725.PubMed
2.
Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994;36:557–565.CrossRefPubMed
3.
Hossmann KA. Neuronal survival and revival during and after cerebral ischemia. Am J Emerg Med 1983;1:191–197.CrossRefPubMed
4.
Read SJ, Hirano T, Abbott DF, et al. The fate of hypoxic tissue on 18F-fluoromisonidazole positron emission tomography after ischemic stroke. Ann Neurol 2000;48:228–235.CrossRefPubMed
5.
Tissue plasminogen activator for acute ischemic stroke. the national institute of neurological disorders and stroke rt-PA stroke study group. N Engl J Med 1995;333:1581–1587.CrossRef
6.
Schellinger PD, Warach S. Therapeutic time window of thrombolytic therapy following stroke. Curr Atheroscler Rep 2004;6:288–294.CrossRefPubMed
7.
Bambauer KZ, Johnston SC, Bambauer DE, Zivin JA. Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol 2006;63:661–664.CrossRefPubMed
8.
Hacke W, Albers G, Al-Rawi Y, et al. The desmoteplase in acute ischemic stroke trial (DIAS): A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66–73.CrossRefPubMed
9.
Furlan AJ, Eyding D, Albers GW, et al. Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): Evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227–1231.CrossRefPubMed
10.
Kaste M. Reborn workhorse, CT, pulls the wagon toward thrombolysis beyond 3 hours. Stroke 2004;35:357–359.CrossRefPubMed
11.
Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508–517.CrossRefPubMed
12.
von Kummer R. Treatment of acute stroke: A misconception. Neuroradiology 2010;52:337–339.CrossRef
13.
Tan JC, Dillon WP, Liu S, Adler F, Smith WS, Wintermark M. Systematic comparison of perfusion-CT and CT-angiography in acute stroke patients. Ann Neurol 2007;61:533–543.CrossRefPubMed
14.
Zaidat OO, Suarez JI, Santillan C, et al. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke 2002;33:1821–1826.CrossRefPubMed
15.
Rubiera M, Ribo M, Delgado-Mederos R, et al. Tandem internal carotid artery/middle cerebral artery occlusion: An independent predictor of poor outcome after systemic thrombolysis. Stroke 2006;37:2301–2305.CrossRefPubMed
16.
Saqqur M, Uchino K, Demchuk AM, et al. Site of arterial occlusion identified by transcranial doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007;38:948–954.CrossRefPubMed
17.
Hopyan J, Ciarallo A, Dowlatshahi D, et al. Certainty of stroke diagnosis: Incremental benefit with CT perfusion over noncontrast CT and CT angiography. Radiology 2010;255:142–153.CrossRefPubMed
18.
Srinivasan A, Goyal M, Al Azri F, Lum C. State-of-the-art imaging of acute stroke. Radiographics 2006;26 (suppl 1):S75–95.CrossRefPubMed
19.
Fiebach JB, Schellinger PD, Jansen O, et al. CT and diffusion-weighted MR imaging in randomized order: Diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke 2002;33:2206–2210.CrossRefPubMed
20.
Saur D, Kucinski T, Grzyska U, et al. Sensitivity and interrater agreement of CT and diffusion-weighted MR imaging in hyperacute stroke. AJNR Am J Neuroradiol 2003;24:878–885.PubMed
21.
Fiehler J, Knudsen K, Kucinski T, et al. Predictors of apparent diffusion coefficient normalization in stroke patients. Stroke 2004;35:514–519.CrossRefPubMed
22.
Mohr JP, Biller J, Hilal SK, et al. Magnetic resonance versus computed tomographic imaging in acute stroke. Stroke 1995;26:807–812.PubMed
23.
Thomalla G, Rossbach P, Rosenkranz M, et al. Negative fluid-attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less. Ann Neurol 2009;65:724–732.CrossRefPubMed
24.
Gonzalez RG, Schaefer P. Conventional MRI and MR angiography of stroke. In: Acute ischemic stroke: imaging and intervention. 1st edn. Berlin: Springer, 2006, 115–137.
25.
Fiebach JB, Schellinger PD, Geletneky K, et al. MRI in acute subarachnoid haemorrhage; findings with a standardised stroke protocol. Neuroradiology 2004;46:44–48.CrossRefPubMed
26.
Boukobza M, Crassard I, Bousser MG, Chabriat H. MR imaging features of isolated cortical vein thrombosis: Diagnosis and follow-up. AJNR Am J Neuroradiol 2009;30:344–348.CrossRefPubMed
27.
Lovblad KO, Bassetti C, Schneider J, et al. Diffusion-weighted MR in cerebral venous thrombosis. Cerebrovasc Dis 2001;11:169–176.CrossRefPubMed
28.
Fiebach JB, Schellinger PD, Gass A, et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: A multicenter study on the validity of stroke imaging. Stroke 2004;35:502–506.CrossRefPubMed
29.
Kidwell CS, Chalela JA, Saver JL, et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 2004;292:1823–1830.CrossRefPubMed
30.
Fiehler J, Albers GW, Boulanger JM, et al. Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): Pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke 2007;38:2738–2744.CrossRefPubMed
31.
32.
Leclerc X, Gauvrit JY, Nicol L, Pruvo JP. Contrast-enhanced MR angiography of the craniocervical vessels: A review. Neuroradiology 1999;41:867–874.CrossRefPubMed
33.
Grandin CB. Assessment of brain perfusion with MRI: Methodology and application to acute stroke. Neuroradiology 2003;45:755–766.CrossRefPubMed
34.
Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249–265.CrossRefPubMed
35.
Wintermark M, Maeder P, Thiran JP, Schnyder P, Meuli R. Quantitative assessment of regional cerebral blood flows by perfusion CT studies at low injection rates: A critical review of the underlying theoretical models. Eur Radiol 2001;11:1220–1230.CrossRefPubMed
36.
Eastwood JD, Lev MH, Provenzale JM. Perfusion CT with iodinated contrast material. AJR Am J Roentgenol 2003;180:3–12.PubMed
37.
Truwit CL, Barkovich AJ, Gean-Marton A, Hibri N, Norman D. Loss of the insular ribbon: Another early CT sign of acute middle cerebral artery infarction. Radiology 1990;176:801–806.PubMed
38.
Tomura N, Uemura K, Inugami A, Fujita H, Higano S, Shishido F. Early CT finding in cerebral infarction: Obscuration of the lentiform nucleus. Radiology 1988;168:463–467.PubMed
39.
Tomsick TA, Brott TG, Chambers AA, et al. Hyperdense middle cerebral artery sign on CT: Efficacy in detecting middle cerebral artery thrombosis. AJNR Am J Neuroradiol 1990;11:473–477.PubMed
40.
Barber PA, Darby DG, Desmond PM, et al. Identification of major ischemic change. diffusion-weighted imaging versus computed tomography. Stroke 1999;30:2059–2065.PubMed
41.
Patel SC, Levine SR, Tilley BC, et al. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA 2001;286:2830–2838.CrossRefPubMed
42.
Roberts HC, Dillon WP, Furlan AJ, et al. Computed tomographic findings in patients undergoing intra-arterial thrombolysis for acute ischemic stroke due to middle cerebral artery occlusion: Results from the PROACT II trial. Stroke 2002;33:1557–1565.CrossRefPubMed
43.
von Kummer R, Bourquain H, Bastianello S, et al. Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology 2001;219:95–100.
44.
Larrue V, von Kummer RR, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: A secondary analysis of the European–Australasian acute stroke study (ECASS II). Stroke 2001;32:438–441.PubMed
45.
Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017–1025.CrossRefPubMed
46.
47.
Lev MH, Farkas J, Rodriguez VR, et al. CT angiography in the rapid triage of patients with hyperacute stroke to intraarterial thrombolysis: Accuracy in the detection of large vessel thrombus. J Comput Assist Tomogr 2001;25:520–528.CrossRefPubMed
48.
Salomon EJ, Barfett J, Willems PW, Geibprasert S, Bacigaluppi S, Krings T. Dynamic CT angiography and CT perfusion employing a 320-detector row CT: Protocol and current clinical applications. Klin Neuroradiol 2009;19:187–196.CrossRefPubMed
49.
Wintermark M, Reichhart M, Thiran JP, et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 2002;51:417–432.CrossRefPubMed
50.
Heiss WD, Sobesky J, Hesselmann V. Identifying thresholds for penumbra and irreversible tissue damage. Stroke 2004;35:2671–2674.CrossRefPubMed
51.
Jansen O, Schellinger P, Fiebach J, Hacke W, Sartor K. Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI. Lancet 1999;353:2036–2037.CrossRefPubMed
52.
Kidwell CS, Alger JR, Saver JL. Beyond mismatch: Evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 2003;34:2729–2735.CrossRefPubMed
53.
Kane I, Carpenter T, Chappell F, et al. Comparison of 10 different magnetic resonance perfusion imaging processing methods in acute ischemic stroke: Effect on lesion size, proportion of patients with diffusion/perfusion mismatch, clinical scores, and radiologic outcomes. Stroke 2007;38:3158–3164.CrossRefPubMed
54.
55.
Wintermark M, Flanders AE, Velthuis B, et al. Perfusion-CT assessment of infarct core and penumbra: Receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke 2006;37:979–985.CrossRefPubMed
56.
Wintermark M, Reichhart M, Cuisenaire O, et al. Comparison of admission perfusion computed tomography and qualitative diffusion- and perfusion-weighted magnetic resonance imaging in acute stroke patients. Stroke 2002;33:2025–2031.CrossRefPubMed
57.
Hacke W, Furlan AJ, Al-Rawi Y, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): A prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009;8:141–150.CrossRefPubMed
58.
Marks MP, Olivot JM, Kemp S, et al. Patients with acute stroke treated with intravenous tPA 3-6 hours after stroke onset: Correlations between MR angiography findings and perfusion- and diffusion-weighted imaging in the DEFUSE study. Radiology 2008;249:614–623.CrossRefPubMed
59.
Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the echoplanar imaging thrombolytic evaluation trial (EPITHET): A placebo-controlled randomised trial. Lancet Neurol 2008;7:299–309.CrossRefPubMed
60.
Wintermark M, Albers GW, Alexandrov AV, et al. Acute stroke imaging research roadmap. AJNR Am J Neuroradiol 2008;29:e23–30.CrossRefPubMed
61.
Provenzale JM, Wintermark M. Optimization of perfusion imaging for acute cerebral ischemia: Review of recent clinical trials and recommendations for future studies. AJR Am J Roentgenol 2008;191:1263–1270.CrossRefPubMed
62.
Kidwell CS, Wintermark M. The Role of CT and MRI in the Emergency Evaluation of Persons with Suspected Stroke. Curr Neurol Neurosci Rep 2010;10:21–28.
Metadata
Title
Neuroimaging of Cerebral Ischemia and Infarction
Authors
Carlos Leiva-Salinas
Max Wintermark
Chelsea S. Kidwell, M.D.
Publication date
01-01-2011
Publisher
Springer-Verlag
Published in
Neurotherapeutics / Issue 1/2011
Print ISSN: 1933-7213
Electronic ISSN: 1878-7479
DOI
https://doi.org/10.1007/s13311-010-0004-2

Other articles of this Issue 1/2011

Neurotherapeutics 1/2011 Go to the issue

OriginalPaper

Neuroimaging in Parkinson’s Disease

PROGRAM

Fourth Annual Huntington Disease Clinical Research Symposium

OriginalPaper

Neuroimaging in Amyotrophic Lateral Sclerosis

OriginalPaper

Optical Coherence Tomography (OCT): Imaging the Visual Pathway as a Model for Neurodegeneration

EditorialNotes

Update in Neuroimaging

Editorial

Transitions and Transformations